1-6 of 6
J Kurtzberg
Close
Sort by
Journal Articles

Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (sVOD) and Multi-Organ Failure (MOF) Post SCT: Final Results of a Multi-Center, Randomized, Dose-Finding Trial.

Paul Richardson, MD, R.J. Soiffer, MD, J.H. Antin, MD, Z. Jin, PhD, J. Kurtzberg, MD, P.L. Martin, MD, G. Steinbach, MD, K.F. Murray, MD, G.B. Vogelsang, MD, A. Chen, MD, A. Krishnan, MD, N.A. Kernan, MD, D. Avigan, MD, T.R. Spitzer, MD, D. Warren, C. Revta, L.J. Wei, PhD, M. Iacobelli, MD, G.B. McDonald, MD, E.C. Guinan, MD
Journal: Blood
Blood (2006) 108 (11): 43.
https://doi.org/10.1182/blood.V108.11.43.43
Published: 2006
Journal Articles

Defibrotide (DF) for the Treatment of Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Analysis of Response and Survival According to Degree and Type of MOF.

Paul G. Richardson, MD, R. J. Soiffer, MD, J. H. Antin, MD, Z. Jin, PhD, J. Kurtzberg, MD, P. L. Martin, MD, D. Hockenbery, MD, K. F. Murray, MD, G. B. Vogelsang, MD, A. Chen, MD, A. Krishnan, MD, N. A. Kernan, MD, D. Avigan, MD, T. R. Spitzer, MD, D. Warren, P. Momtaz, C. Revta, L. J. Wei, PhD, M. Iacobelli, MD, G. B. McDonald, MD, E. C. Guinan, MD
Journal: Blood
Blood (2005) 106 (11): 399.
https://doi.org/10.1182/blood.V106.11.399.399
Published: 2005
Journal Articles

Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Final Results of a Phase II, Multicenter, Randomized Study and Preliminary Analyses of Surrogate Markers and Ultrasound Findings.

Paul G. Richardson, MD, R. J. Soiffer, MD, J. H. Antin, MD, S. D. Voss, MD, PhD, Z. Jin, PhD, J. Kurtzberg, MD, P. L. Martin, MD, D. Hockenbery, MD, K. F. Murray, MD, G. B. Vogelsang, MD, A. Chen, MD, A. Krishnan, MD, N. A. Kernan, MD, D. Avigan, MD, T. R. Spitzer, MD, R. Iannone, MD, S. Giralt, MD, D. Warren, P. Momtaz, G. Bradwin, M. Iacobelli, MD, G. B. McDonald, MD, E. C. Guinan, MD
Journal: Blood
Blood (2004) 104 (11): 350.
https://doi.org/10.1182/blood.V104.11.350.350
Published: 2004
Journal Articles

A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia

DC Dale, MA Bonilla, MW Davis, AM Nakanishi, WP Hammond, J Kurtzberg, W Wang, A Jakubowski, E Winton, P Lalezari
Journal: Blood
Blood (1993) 81 (10): 2496–2502.
https://doi.org/10.1182/blood.V81.10.2496.2496
Published: 1993
Journal Articles

Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy

WP Peters, G Rosner, M Ross, J Vredenburgh, B Meisenberg, C Gilbert, J Kurtzberg
Journal: Blood
Blood (1993) 81 (7): 1709–1719.
https://doi.org/10.1182/blood.V81.7.1709.1709
Published: 1993
Journal Articles

CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells

J Kurtzberg, TA Waldmann, MP Davey, SH Bigner, JO Moore, MS Hershfield, BF Haynes
Journal: Blood
Blood (1989) 73 (2): 381–390.
https://doi.org/10.1182/blood.V73.2.381.381
Published: 1989